Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 112,359,768
  • Shares Outstanding, K 1,483,885
  • Annual Sales, $ 20,074 M
  • Annual Income, $ 2,898 M
  • EBIT $ 4,510 M
  • EBITDA $ 6,165 M
  • 60-Month Beta 0.67
  • Price/Sales 5.64
  • Price/Cash Flow 18.90
  • Price/Book 4.63

Options Overview Details

View History
  • Implied Volatility 30.08% (+1.63%)
  • Historical Volatility 59.91%
  • IV Percentile 76%
  • IV Rank 35.98%
  • IV High 52.68% on 04/04/25
  • IV Low 17.38% on 07/29/25
  • Expected Move (DTE 7) 2.13 (2.85%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 43,540
  • Volume Avg (30-Day) 33,449
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 484,492
  • Open Int (30-Day) 412,135
  • Expected Range 72.46 to 76.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.79
  • Number of Estimates 9
  • High Estimate 0.80
  • Low Estimate 0.78
  • Prior Year 0.75
  • Growth Rate Est. (year over year) +5.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.69 +2.60%
on 02/11/26
94.75 -21.29%
on 01/26/26
-16.62 (-18.22%)
since 01/20/26
3-Month
72.69 +2.60%
on 02/11/26
101.91 -26.82%
on 12/01/25
-22.02 (-22.80%)
since 11/20/25
52-Week
72.69 +2.60%
on 02/11/26
109.50 -31.89%
on 09/09/25
-30.78 (-29.21%)
since 02/20/25

Most Recent Stories

More News
Ongoing Investigation: Boston Scientific Corporation (BSX) May Have Misled Shareholders - Levi & Korsinsky Investigates

New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation")...

BSX : 74.58 (-1.51%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX

NEW YORK , Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX). Such...

BSX : 74.58 (-1.51%)
3 S&P 500 Stocks Worth Investigating

3 S&P 500 Stocks Worth Investigating

TT : 467.12 (+0.74%)
BSX : 74.58 (-1.51%)
ZTS : 128.78 (+1.18%)
Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

MARLBOROUGH, Mass. , Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46 th Annual Health Care Conference on Tuesday, March 3, 2026. Mike...

BSX : 74.58 (-1.51%)
The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call

The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call

BSX : 74.58 (-1.51%)
Levi & Korsinsky Investigates Possible Securities Fraud by Boston Scientific Corporation (BSX)

New York, New York--(Newsfile Corp. - February 10, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific...

BSX : 74.58 (-1.51%)
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Boston Scientific Corporation (“Boston Scientific”...

BSX : 74.58 (-1.51%)
Fraud Investigation Opened: Levi & Korsinsky Investigates Boston Scientific Corporation (BSX) on Behalf of Shareholders

New York, New York--(Newsfile Corp. - February 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation")...

BSX : 74.58 (-1.51%)
3 Safe-and-Steady Stocks to Consider Right Now

3 Safe-and-Steady Stocks to Consider Right Now

BR : 177.02 (+0.46%)
INTU : 380.55 (-0.26%)
BSX : 74.58 (-1.51%)
Boston Scientific Corporation (BSX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX ) investors concerning the...

BSX : 74.58 (-1.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 76.41
2nd Resistance Point 75.99
1st Resistance Point 75.29
Last Price 74.58
1st Support Level 74.17
2nd Support Level 73.75
3rd Support Level 73.05

See More

52-Week High 109.50
Fibonacci 61.8% 95.44
Fibonacci 50% 91.10
Fibonacci 38.2% 86.75
Last Price 74.58
52-Week Low 72.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar